mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.13 |
0.03 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |